Heart Failure Summit Addresses New Therapies and Devices for Heart Disease
Needham, MA (PRWEB) September 27, 2016 -- Clinicians have diagnosed over 30 million people with heart failure in the United States. A syndrome characterized by high mortality, frequent hospitalization and reduced quality of life, heart failure is difficult to treat and about 50% of patients will die from it within five years of a diagnosis.
Improving clinicians’ understanding of heart failure pathophysiology, new medications, surgical interventions and mechanical devices is our best hope in the face of such stark statistics.
Beginning today, September 27th, CardioCareLive is hosting the Heart Failure Summit, a three-part complementary CME program for cardiologists, internal medicine and primary care physicians, nurses and other health care professionals that treat patients with heart failure.
Advances in Heart Failure Management: Improving Outcomes with Innovation
September 27, 2016: 1:00 – 3:00PM EST
November 1, 2016: 2:00 PM – 3:00 PM EST
Taught by cardiac specialists and professors from Harvard Medical School — Doctors James L. Januzzi, Akshay Suvas Desai and Jagmeet P. Singh— the program aims to provide practical guidance on recent advances in heart failure management to facilitate informed, individualized treatment decisions.
“Heart failure is an increasingly prevalent diagnosis, associated with high risk and spiraling healthcare costs. Clinicians will benefit from an understanding of optimal means to identify and treat this escalating problem," says James L. Januzzi, MD, FACC, FESC and Professor of Medicine at Harvard Medical School.
Clinicians can learn more and register here. The entire heart failure program will also be available on demand after the live airing.
Megan Cater, PlatformQ Health, http://www.platformqhealth.com/, +1 (617) 938-6031, [email protected]
Share this article